Sarbari Ghosh

894 total citations
20 papers, 636 citations indexed

About

Sarbari Ghosh is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Sarbari Ghosh has authored 20 papers receiving a total of 636 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Immunology, 7 papers in Molecular Biology and 4 papers in Oncology. Recurrent topics in Sarbari Ghosh's work include Immunotherapy and Immune Responses (9 papers), Immune cells in cancer (6 papers) and Immune Cell Function and Interaction (5 papers). Sarbari Ghosh is often cited by papers focused on Immunotherapy and Immune Responses (9 papers), Immune cells in cancer (6 papers) and Immune Cell Function and Interaction (5 papers). Sarbari Ghosh collaborates with scholars based in India and United States. Sarbari Ghosh's co-authors include Rathindranath Baral, Anamika Bose, Tithi Ghosh, Madhurima Sarkar, Kuntal Kanti Goswami, Subhasis Barik, Avishek Bhuniya, Saptak Banerjee, Atharva Karulkar and Alka Dwivedi and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and International Journal of Cancer.

In The Last Decade

Sarbari Ghosh

20 papers receiving 627 citations

Peers

Sarbari Ghosh
Irwin Freed United States
Uksha Saini United States
Se Jin Oh South Korea
Huizhen Suo Germany
Sarbari Ghosh
Citations per year, relative to Sarbari Ghosh Sarbari Ghosh (= 1×) peers Tithi Ghosh

Countries citing papers authored by Sarbari Ghosh

Since Specialization
Citations

This map shows the geographic impact of Sarbari Ghosh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarbari Ghosh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarbari Ghosh more than expected).

Fields of papers citing papers by Sarbari Ghosh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarbari Ghosh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarbari Ghosh. The network helps show where Sarbari Ghosh may publish in the future.

Co-authorship network of co-authors of Sarbari Ghosh

This figure shows the co-authorship network connecting the top 25 collaborators of Sarbari Ghosh. A scholar is included among the top collaborators of Sarbari Ghosh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarbari Ghosh. Sarbari Ghosh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Roy, Kamalika, Avishek Bhuniya, Sarbari Ghosh, et al.. (2024). High monocytic MDSC signature predicts multi-drug resistance and cancer relapse in non-Hodgkin lymphoma patients treated with R-CHOP. Frontiers in Immunology. 14. 1303959–1303959. 10 indexed citations
2.
Kumar, Sushant, Sarbari Ghosh, Farhat Ali Khan, et al.. (2021). Multiomics Analysis and Systems Biology Integration Identifies the Roles of IL-9 in Keratinocyte Metabolic Reprogramming. Journal of Investigative Dermatology. 141(8). 1932–1942. 11 indexed citations
3.
Kar, Subrat Kumar, Biplab Kumar Paul, Sarbari Ghosh, et al.. (2021). Derivation of an empirical relation between the size of the nanoparticle and the potency of homeopathic medicines. International Journal of High Dilution Research - ISSN 1982-6206. 14(4). 2–7. 6 indexed citations
4.
Sarkar, Madhurima, Avishek Bhuniya, Sarbari Ghosh, et al.. (2021). Neem leaf glycoprotein salvages T cell functions from Myeloid-derived suppressor cells-suppression by altering IL-10/STAT3 axis in melanoma tumor microenvironment. Melanoma Research. 31(2). 130–139. 4 indexed citations
5.
Kumar, Sushant, Sarbari Ghosh, Alka Dwivedi, et al.. (2020). The Th9 Axis Reduces the Oxidative Stress and Promotes the Survival of Malignant T Cells in Cutaneous T-Cell Lymphoma Patients. Molecular Cancer Research. 18(4). 657–668. 23 indexed citations
6.
Bhuniya, Avishek, Partha Nandi, Sarbari Ghosh, et al.. (2020). NLGP Attenuates Murine Melanoma and Carcinoma Metastasis by Modulating Cytotoxic CD8+ T Cells. Frontiers in Oncology. 10. 201–201. 8 indexed citations
7.
Bhuniya, Avishek, Partha Nandi, Sarbari Ghosh, et al.. (2020). Neem Leaf Glycoprotein Reverses Tumor-Induced and Age-Associated Thymic Involution to Maintain Peripheral CD8 + T Cell Pool. Immunotherapy. 12(11). 799–818. 4 indexed citations
8.
Dwivedi, Alka, et al.. (2019). Lymphocytes in Cellular Therapy: Functional Regulation of CAR T Cells. Frontiers in Immunology. 9. 3180–3180. 58 indexed citations
9.
Ghosh, Sarbari, Madhurima Sarkar, Tithi Ghosh, et al.. (2017). Neem leaf glycoprotein generates superior tumor specific central memory CD8+ T cells than cyclophosphamide that averts post-surgery solid sarcoma recurrence. Vaccine. 35(34). 4421–4429. 5 indexed citations
10.
Sarkar, Madhurima, Sarbari Ghosh, Avishek Bhuniya, et al.. (2017). Neem leaf glycoprotein prevents post-surgical sarcoma recurrence in Swiss mice by differentially regulating cytotoxic T and myeloid-derived suppressor cells. PLoS ONE. 12(4). e0175540–e0175540. 6 indexed citations
11.
Goswami, Kuntal Kanti, Tithi Ghosh, Sarbari Ghosh, et al.. (2017). Tumor promoting role of anti-tumor macrophages in tumor microenvironment. Cellular Immunology. 316. 1–10. 264 indexed citations
12.
Ghosh, Sarbari, Madhurima Sarkar, Tithi Ghosh, et al.. (2016). Absence of CD4+ T cell help generates corrupt CD8+ effector T cells in sarcoma-bearing Swiss mice treated with NLGP vaccine. Immunology Letters. 175. 31–39. 16 indexed citations
13.
Goswami, Kuntal Kanti, Madhurima Sarkar, Sarbari Ghosh, et al.. (2016). Neem leaf glycoprotein regulates function of tumor associated M2 macrophages in hypoxic tumor core: Critical role of IL-10/STAT3 signaling. Molecular Immunology. 80. 1–10. 21 indexed citations
14.
Ghosh, Tithi, Subhasis Barik, Avishek Bhuniya, et al.. (2016). Tumor‐associated mesenchymal stem cells inhibit naïve T cell expansion by blocking cysteine export from dendritic cells. International Journal of Cancer. 139(9). 2068–2081. 37 indexed citations
15.
Roy, Soumyabrata, Kai Lǚ, Mukti Kant Nayak, et al.. (2016). Activation of D2 Dopamine Receptors in CD133+ve Cancer Stem Cells in Non-small Cell Lung Carcinoma Inhibits Proliferation, Clonogenic Ability, and Invasiveness of These Cells. Journal of Biological Chemistry. 292(2). 435–445. 41 indexed citations
16.
Banerjee, Saptak, Tithi Ghosh, Subhasis Barik, et al.. (2014). Neem Leaf Glycoprotein Prophylaxis Transduces Immune Dependent Stop Signal for Tumor Angiogenic Switch within Tumor Microenvironment. PLoS ONE. 9(11). e110040–e110040. 35 indexed citations
17.
Barik, Subhasis, Sarbari Ghosh, Soumyabrata Roy, et al.. (2014). Immunotherapeutic Targeting of Established Sarcoma in Swiss Mice by Tumor-derived Antigen-pulsed NLGP Matured Dendritic Cells is CD8 + T-cell Dependent. Immunotherapy. 6(7). 821–831. 7 indexed citations
19.
Barik, Subhasis, Kuntal Kanti Goswami, Saptak Banerjee, et al.. (2013). Neem Leaf Glycoprotein Activates CD8+ T Cells to Promote Therapeutic Anti-Tumor Immunity Inhibiting the Growth of Mouse Sarcoma. PLoS ONE. 8(1). e47434–e47434. 37 indexed citations
20.
Ghosh, Sarbari, Saptak Banerjee, Subhasis Barik, et al.. (2012). Neem leaf glycoprotein is nontoxic to physiological functions of Swiss mice and Sprague Dawley rats: Histological, biochemical and immunological perspectives. International Immunopharmacology. 15(1). 73–83. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026